CRISPR Gene Editing Newsletter
Issue #25February 23, 20267 studies

Gene editing in mouse brains fixes autism-like behaviors caused by genetic mutations

This week brought remarkable progress in using CRISPR gene editing to treat diseases once thought untreatableโ€”from fixing genetic brain disorders in living mice to engineering better tools for precise DNA editing.

๐Ÿง  Gene editing reverses autism-like behaviors in mice with brain disorder

  • Researchers used a new gene editing tool called TeABE to fix a genetic mutation (CHD3 p.R1025W) that causes Snijders Blok-Campeau syndrome, a disorder marked by intellectual disability and autism-like behaviors

  • The treatment was delivered directly to mouse brains using engineered viruses and successfully corrected the mutation across multiple brain regions, restoring normal protein levels

  • Treated mice showed significant improvements in social communication, learning, and motor coordination compared to untreated mice with the same genetic mutation

Why it matters: This demonstrates that precise gene editing can reverse complex behavioral and cognitive symptoms even after birth, offering hope for treating genetic neurodevelopmental disorders in humans.

๐Ÿ† Top 0.1% journal ๐Ÿ”— Nature ๐Ÿ—“๏ธ Feb 18

Key Findings

๐Ÿ”ง New compact CRISPR tool dramatically expands genome editing targets

  • Engineers created evoCas12f, a smaller gene editing tool that recognizes 16 times more DNA target sites than previous versions by expanding from TTTR sequences to NTNR/NYTR patterns

  • The improved tool achieved up to 91% editing efficiency and successfully created genetic changes in newborn mice, even at previously inaccessible DNA sites

  • The compact size makes it suitable for gene therapy delivery methods that have strict size limitations, like certain viral vectors

๐Ÿ’ก This engineering advance could make gene editing treatments accessible for many more genetic diseases.
๐Ÿฅˆ Top 2% journal ๐Ÿ”— Nature communications ๐Ÿ—“๏ธ Feb 18

๐Ÿ’Š Gene editing prevents heart failure by blocking a key protein switch

  • Scientists used CRISPR to edit the PKCฮฑ gene, preventing a critical protein modification (T497 phosphorylation) that normally triggers heart failure pathways

  • Mice with the edited gene were protected from heart failure symptoms, cardiac enlargement, and lung congestion after surgical stress that normally causes heart failure

  • The same editing approach worked in human heart cells grown from stem cells, suggesting potential clinical applications

๐Ÿ’ก Targeting specific protein modifications rather than entire genes could offer more precise treatments for heart disease.
๐Ÿฅ‡ Top 1% journal ๐Ÿ”— Circulation research ๐Ÿ—“๏ธ Feb 20

๐Ÿงช Simple nutrient boost improves gene editing accuracy 4-fold

  • Adding thymidine (a DNA building block) to cell cultures increased the efficiency of C-to-A gene editing by up to 4-fold and improved editing precision by 2.7-fold

  • The supplement works by elevating cellular levels of dTTP, which helps DNA repair machinery insert the correct bases during the editing process

  • This metabolic approach enabled researchers to create disease-relevant mutations that were previously too inefficient to generate reliably

๐Ÿ’ก Manipulating cellular metabolism could be a simple way to improve gene editing outcomes without redesigning the editing tools themselves.
๐Ÿฅˆ Top 2% journal ๐Ÿ”— Theranostics ๐Ÿ—“๏ธ Feb 16

๐ŸŒฑ Gene editing reaches woody plants through direct delivery to growing tips

  • Researchers successfully edited genes in citrus and poplar trees by shooting CRISPR proteins directly into actively growing stem tips using particle bombardment

  • This approach bypassed the need for lengthy tissue culture processes that often fail in woody plants, generating edited plants more efficiently

  • The method produced some plants with mixed edited and unedited cells, but provides a pathway for creating transgene-free edited trees

๐Ÿ’ก Direct editing of plant growing points could accelerate development of improved crops and forest trees.
๐ŸŽ–๏ธ Top 10% journal ๐Ÿ”— Plant cell reports ๐Ÿ—“๏ธ Feb 17

๐Ÿฆ  CRISPR gene drives show minimal mutation burden in safety study

  • A comprehensive mutation analysis in yeast found that CRISPR gene drives increased genome-wide mutation rates by less than 30%โ€”much less than natural variation between organisms

  • The study tracked thousands of generations to measure unintended DNA changes and loss-of-heterozygosity events that could harm wild populations

  • Statistical analysis showed the mutation burden was so low it was barely detectable above background levels

๐Ÿ’ก These safety data support the idea that well-designed gene drives may pose acceptable evolutionary risks for pest control applications.
Top 30% journal ๐Ÿ”— G3 (Bethesda, Md.) ๐Ÿ—“๏ธ Feb 18

๐Ÿ” CRISPR screening reveals new drug target for liver cancer resistance

  • Genome-wide CRISPR screening identified ATOX1 as a key gene that helps liver cancer cells survive cisplatin chemotherapy

  • Researchers developed compound 8, which binds to ATOX1 protein with 12.5 ฮผM affinity and shows synergistic effects when combined with cisplatin

  • The compound works by disrupting copper metabolism and activating DNA methylation pathways that make cancer cells more sensitive to treatment

๐Ÿ’ก Targeting copper-handling proteins could help overcome chemotherapy resistance in liver cancer patients.
๐Ÿฅ‰ Top 5% journal ๐Ÿ”— Communications biology ๐Ÿ—“๏ธ Feb 16

Implications

These studies showcase CRISPR's evolution from a research tool to a therapeutic platform, with successful treatments now working in living brains and new engineering approaches making gene editing more precise and accessible. The combination of improved delivery methods, enhanced editing tools, and better understanding of cellular metabolism is rapidly expanding what genetic diseases might be treatable.

Studies in this issue

Primary sources used for this newsletter.

  1. Stopping PKCฮฑ Activation with Gene Editing May Improve Heart Failure
    key findingCirculation research2026-02-20PMID 41717698
  2. Maximum mutation load caused by a CRISPR-Cas9 gene drive element
    key findingG3 (Bethesda, Md.)2026-02-18PMID 41706533